Skip to main content

Isoproterenol Pregnancy and Breastfeeding Warnings

Brand names: Isuprel, Isuprel Mistometer, Medihaler-Iso

Medically reviewed by Drugs.com. Last updated on Mar 5, 2024.

Isoproterenol Pregnancy Warnings

Animal studies have not been reported. There are no controlled data in human pregnancy.

AU TGA pregnancy category A: Drugs which have been taken by a large number of pregnant women and women of childbearing age without any proven increase in the frequency of malformations or other direct or indirect harmful effects on the fetus having been observed.

US FDA pregnancy category C: Animal reproduction studies have shown an adverse effect on the fetus and there are no adequate and well-controlled studies in humans, but potential benefits may warrant use of the drug in pregnant women despite potential risks.

This drug should be used during pregnancy only if clearly needed and the benefit outweighs the risk.

AU TGA pregnancy category: A
US FDA pregnancy category: C

See references

Isoproterenol Breastfeeding Warnings

Caution is recommended.

Excreted into human milk: Unknown
Excreted into animal milk: Data not available

Comments: The effects in the nursing infant are unknown.

See references

See also

References for pregnancy information

  1. Cerner Multum, Inc. Australian Product Information.
  2. Product Information. Isuprel HCl (isoproterenol). Hospira Inc. 2017.

References for breastfeeding information

  1. Cerner Multum, Inc. Australian Product Information.
  2. Product Information. Isuprel HCl (isoproterenol). Hospira Inc. 2017.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.

Medical Disclaimer